NASDAQ:GNMX - Aevi Genomic Medicine News Headlines

$0.19
0.00 (0.00 %)
(As of 08/22/2019 01:40 AM ET)
Today's Range
$0.1901
Now: $0.1930
$0.20
50-Day Range
$0.16
MA: $0.18
$0.28
52-Week Range
$0.15
Now: $0.1930
$1.40
Volume418,217 shs
Average Volume2.13 million shs
Market Capitalization$12.50 million
P/E RatioN/A
Dividend YieldN/A
Beta0.73

Headlines

Aevi Genomic Medicine (NASDAQ GNMX) News Headlines

Source:
DateHeadline
Aevi Genomic Medicine Inc (NASDAQ:GNMX) Sees Significant Increase in Short InterestAevi Genomic Medicine Inc (NASDAQ:GNMX) Sees Significant Increase in Short Interest
www.americanbankingnews.com - August 13 at 2:37 PM
Aevi Genomic Medicine Inc (NASDAQ:GNMX) Expected to Post Earnings of -$0.10 Per ShareAevi Genomic Medicine Inc (NASDAQ:GNMX) Expected to Post Earnings of -$0.10 Per Share
www.americanbankingnews.com - August 10 at 4:20 AM
Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 AntibodyAevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 Antibody
finance.yahoo.com - August 7 at 9:37 AM
Aevi Genomic Medicine to Present at the 2019 Wedbush PacGrow Healthcare ConferenceAevi Genomic Medicine to Present at the 2019 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 6 at 9:15 AM
Aevi Genomic Med up 23% after hours on Astellas dealAevi Genomic Med up 23% after hours on Astellas deal
seekingalpha.com - July 15 at 6:51 PM
Aevi Genomic Medicine Enters into Worldwide License Agreement with Astellas to Develop and Commercialize a Novel Second Generation mTORC1/2 InhibitorAevi Genomic Medicine Enters into Worldwide License Agreement with Astellas to Develop and Commercialize a Novel Second Generation mTORC1/2 Inhibitor
finance.yahoo.com - July 15 at 6:51 PM
Aevi Genomic Medicine Inc.Aevi Genomic Medicine Inc.
www.barrons.com - April 30 at 6:48 PM
Factors of Influence in 2019, Key Indicators and Opportunity within Park Hotels & Resorts, Planet Fitness, Aevi Genomic Medicine, Ardelyx, AMERISAFE, and inTest — New Research Emphasizes Economic GrowthFactors of Influence in 2019, Key Indicators and Opportunity within Park Hotels & Resorts, Planet Fitness, Aevi Genomic Medicine, Ardelyx, AMERISAFE, and inTest — New Research Emphasizes Economic Growth
finance.yahoo.com - February 12 at 8:27 AM
GNMX: ASCEND Misses Primary Endpoint: GNMX indicates they are not giving up in AEVI-001GNMX: ASCEND Misses Primary Endpoint: GNMX indicates they are not giving up in AEVI-001
finance.yahoo.com - January 22 at 6:19 PM
The Daily Biotech Pulse: Aevis ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With AmgenThe Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen
finance.yahoo.com - January 4 at 8:14 AM
Aevi Genomics AEVI-001 flunks mid-stage ADHD studyAevi Genomic's AEVI-001 flunks mid-stage ADHD study
seekingalpha.com - January 2 at 5:26 PM
Aevi Genomic Medicine Announces Top-Line Results from Placebo-Controlled ASCEND Trial (Parts A & B) of AEVI-001 in Children with ADHDAevi Genomic Medicine Announces Top-Line Results from Placebo-Controlled ASCEND Trial (Parts A & B) of AEVI-001 in Children with ADHD
finance.yahoo.com - January 2 at 5:26 PM
Aevi Genomic Medicine to Host KOL Breakfast to Discuss Diagnosis and Treatment Paradigms in ADHDAevi Genomic Medicine to Host KOL Breakfast to Discuss Diagnosis and Treatment Paradigms in ADHD
finance.yahoo.com - November 26 at 8:21 AM
Detailed Research: Economic Perspectives on Gogo, Aevi Genomic Medicine, PBF Energy, SiteOne Landscape Supply, Douglas Dynamics, and Dine Brands Global — What Drives Growth in Todays Competitive LandscapeDetailed Research: Economic Perspectives on Gogo, Aevi Genomic Medicine, PBF Energy, SiteOne Landscape Supply, Douglas Dynamics, and Dine Brands Global — What Drives Growth in Today's Competitive Landscape
finance.yahoo.com - November 8 at 8:28 AM
GNMX: With ASCEND Enrollment Completed, Read-Out Expected In Q1’19GNMX: With ASCEND Enrollment Completed, Read-Out Expected In Q1’19
finance.yahoo.com - November 5 at 5:19 PM
Aevi Genomic Medicine: 3Q Earnings SnapshotAevi Genomic Medicine: 3Q Earnings Snapshot
finance.yahoo.com - November 1 at 5:56 PM
Aevi Genomic Medicine Reports Third Quarter 2018 Financial Results and Provides Business UpdateAevi Genomic Medicine Reports Third Quarter 2018 Financial Results and Provides Business Update
finance.yahoo.com - November 1 at 8:15 AM
New Research Coverage Highlights Amtech, Neos Therapeutics, FTD Companies, John B. Sanfilippo & Son, Molecular ...New Research Coverage Highlights Amtech, Neos Therapeutics, FTD Companies, John B. Sanfilippo & Son, Molecular ...
globenewswire.com - October 18 at 8:31 AM
New Research Coverage Highlights Amtech, Neos Therapeutics, FTD Companies, John B. Sanfilippo & Son, Molecular Templates, and Aevi Genomic Medicine — Consolidated Revenues, Company Growth, and Expectations for 2018New Research Coverage Highlights Amtech, Neos Therapeutics, FTD Companies, John B. Sanfilippo & Son, Molecular Templates, and Aevi Genomic Medicine — Consolidated Revenues, Company Growth, and Expectations for 2018
finance.yahoo.com - October 16 at 8:29 AM
Aevi Genomic Medicine advancing mid-stage study of AEVI-001 in ADHD; shares up 2%Aevi Genomic Medicine advancing mid-stage study of AEVI-001 in ADHD; shares up 2%
seekingalpha.com - October 15 at 5:01 PM
Aevi Genomic Medicine Announces Completion of Enrollment for Part B of the ASCEND TrialAevi Genomic Medicine Announces Completion of Enrollment for Part B of the ASCEND Trial
finance.yahoo.com - October 15 at 8:26 AM
Global Genetic Modification Therapies Clinical Applications Market to 2023Global Genetic Modification Therapies Clinical Applications Market to 2023
globenewswire.com - September 27 at 4:51 PM
Aevi Genomic Medicine (GNMX) Presents At Rodman & Renshaw.C. Wainwright 20th Annual Global Investment Conference - SlideshowAevi Genomic Medicine (GNMX) Presents At Rodman & Renshaw.C. Wainwright 20th Annual Global Investment Conference - Slideshow
seekingalpha.com - September 6 at 5:00 PM
Aevi Genomic Medicine to Present at the H.C. Wainwright 20th Annual Global Investment ConferenceAevi Genomic Medicine to Present at the H.C. Wainwright 20th Annual Global Investment Conference
finance.yahoo.com - August 29 at 8:36 AM
Aevi Genomic Medicine Announces Capital Raise of $4.9M to Accelerate Part B of the ASCEND TrialAevi Genomic Medicine Announces Capital Raise of $4.9M to Accelerate Part B of the ASCEND Trial
finance.yahoo.com - August 21 at 8:27 AM
Aevi Genomic Medicine Announces Completion of Enrollment in Part A of Phase 2 ASCEND Trial in ADHDAevi Genomic Medicine Announces Completion of Enrollment in Part A of Phase 2 ASCEND Trial in ADHD
finance.yahoo.com - August 14 at 8:31 AM
GNMX: AEVI Q2 Update: ASCEND Data By Year-End, Enhanced 001 Co-CrystalGNMX: AEVI Q2 Update: ASCEND Data By Year-End, Enhanced 001 Co-Crystal
finance.yahoo.com - August 13 at 5:40 PM
Aevi Genomic Medicine: 2Q Earnings SnapshotAevi Genomic Medicine: 2Q Earnings Snapshot
finance.yahoo.com - August 2 at 5:24 PM
Aevi Genomic Medicine Reports Second Quarter 2018 Financial Results and Provides Business UpdateAevi Genomic Medicine Reports Second Quarter 2018 Financial Results and Provides Business Update
finance.yahoo.com - August 2 at 8:29 AM
Aevi Genomic Medicine announces new co-crystal version of fasoracetamAevi Genomic Medicine announces new co-crystal version of fasoracetam
seekingalpha.com - July 19 at 4:42 PM
Aevi Genomic Medicine, Inc. Announces Novel Co-crystal Version of AEVI-001Aevi Genomic Medicine, Inc. Announces Novel Co-crystal Version of AEVI-001
finance.yahoo.com - July 19 at 4:42 PM
GNMX: ASCEND Will Enroll To N=64, (consistent with initial trial design)GNMX: ASCEND Will Enroll To N=64, (consistent with initial trial design)
finance.yahoo.com - June 20 at 5:52 PM
Aevi Genomic Medicine (GNMX) Reports Update to Size Sample for Part A of Phase 2 ASCEND Clinical Trial in ADHDAevi Genomic Medicine (GNMX) Reports Update to Size Sample for Part A of Phase 2 ASCEND Clinical Trial in ADHD
www.streetinsider.com - June 13 at 8:26 AM
Aevi Genomic Medicine to Present at the The 2018 JMP Securities Life Sciences ConferenceAevi Genomic Medicine to Present at the The 2018 JMP Securities Life Sciences Conference
finance.yahoo.com - June 13 at 8:26 AM
Aevi Genomic Medicine boost sample size in mid-stage ADHD study of AEVI-001Aevi Genomic Medicine boost sample size in mid-stage ADHD study of AEVI-001
seekingalpha.com - June 12 at 5:00 PM
Aevi Genomic Medicine Provides Update on Sample Size Re-estimation for Phase 2 ASCEND Trial in ADHDAevi Genomic Medicine Provides Update on Sample Size Re-estimation for Phase 2 ASCEND Trial in ADHD
finance.yahoo.com - June 12 at 8:24 AM
GNMX: Development Timelines Intact, Including AEVI-001 Ph2 ADHD Data Expected ~Mid-YearGNMX: Development Timelines Intact, Including AEVI-001 Ph2 ADHD Data Expected ~Mid-Year
finance.yahoo.com - June 6 at 5:23 PM
Aevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare ConferenceAevi Genomic Medicine to Present at the Jefferies 2018 Global Healthcare Conference
finance.yahoo.com - May 29 at 8:30 AM
Wired News - uniQure Announced Presentation of Preclinical Data Demonstrating Advances in Distribution of Gene Therapy at ASGCT Annual Meeting in ChicagoWired News - uniQure Announced Presentation of Preclinical Data Demonstrating Advances in Distribution of Gene Therapy at ASGCT Annual Meeting in Chicago
finance.yahoo.com - May 22 at 8:23 AM
Aevi Genomic Medicine: Try Subgroups Until It Works?Aevi Genomic Medicine: Try Subgroups Until It Works?
seekingalpha.com - May 20 at 5:50 PM
Aevi Genomic Medicine: 1Q Earnings SnapshotAevi Genomic Medicine: 1Q Earnings Snapshot
finance.yahoo.com - May 15 at 5:45 PM
Aevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business UpdateAevi Genomic Medicine Reports First Quarter 2018 Financial Results and Provides Business Update
finance.yahoo.com - May 15 at 8:36 AM
What Are Analysts Expecting From Aevi Genomic Medicine Inc (NASDAQ:GNMX) Over The Next Few Years?What Are Analysts Expecting From Aevi Genomic Medicine Inc (NASDAQ:GNMX) Over The Next Few Years?
finance.yahoo.com - May 8 at 5:32 PM
Form DEF 14A Sage Therapeutics, Inc. For: Jun 06Form DEF 14A Sage Therapeutics, Inc. For: Jun 06
www.streetinsider.com - April 30 at 5:10 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of ...SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of ...
www.businesswire.com - April 30 at 5:10 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMXSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aevi Genomic Medicine, Inc. -- GNMX
finance.yahoo.com - April 30 at 5:10 PM
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of DirectorsSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Aevi Genomic Medicine, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
www.prnewswire.com - April 29 at 8:54 PM
Investor Expectations to Drive Momentum within Brooks Automation, Broadridge Financial Solutions, Vivint Solar, Northwest Natural Gas, Aevi Genomic Medicine, and Northern Oil and Gas — Discovering Underlying Factors of InfluenceInvestor Expectations to Drive Momentum within Brooks Automation, Broadridge Financial Solutions, Vivint Solar, Northwest Natural Gas, Aevi Genomic Medicine, and Northern Oil and Gas — Discovering Underlying Factors of Influence
finance.yahoo.com - April 6 at 8:35 AM
GNMX: Q4 2017 Results / Operational UpdateGNMX: Q4 2017 Results / Operational Update
finance.yahoo.com - March 22 at 5:31 PM
GNMX: ASCEND Timeline On-Track, Topline ~Mid-2018. Additional Pipeline ExpansionGNMX: ASCEND Timeline On-Track, Topline ~Mid-2018. Additional Pipeline Expansion
finance.yahoo.com - March 22 at 5:31 PM
This page was last updated on 8/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel